• 12339 - Chovatiya
    Patient and Healthcare Provider Perspectives on the Disease Burden of Seborrheic Dermatitis in the United States: Results From a National Survey
    Raj Chovatiya, Lakshi Aldredge, Candrice Heath, Moises Acevedo, David H. Chu, Diane Hanna, Melissa Seal, Matt Zirwas
    Poster Abstract

  • 12350 - Christianson
    Challenges in diagnosing and managing generalized pustular psoriasis: Learnings from 4 cases in clinical practice
    Ellie Christianson, Jayme Heim, Leigh Ann Pansch, Henry Yu
    Poster Abstract

  • 12340 - Del Rosso
    One Dose Fits All: Once Daily Subantibiotic Dose Oral Doxycycline 40 mg Modified-release Capsules Effective in Different BMIs and Across Severities of Papulopustular Rosacea
    James Q. Del Rosso, DO; Sam Brantman, PharmD; Neal D. Bhatia, MD
    Poster Abstract

  • 12341 - Deodhar
    Long-term Safety of Ixekizumab in Adult Patients with Psoriasis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Atul Deodhar, Andrew Blauvelt, Sergio Schwartzman, Carlo Salvarani, Meghan Feely, Andris Kronbergs, Nadia Eberhart, Danting Zhu, Elsa Mevel, Thorsten Holzkaemper, Eswar Krishnan, Mark Lebwohl, Proton Rahman, Helena Marzo-Ortega
    Poster Abstract

  • 12342 - Draelos
    Impact of Seasonal Variation on the Efficacy and Safety of Tazarotene 0.045% Lotion for Acne: Post Hoc Analysis of Pooled Phase 3 Data
    Zoe D. Draelos; Emil A. Tanghetti; Melinda J. Gooderham; Andrew F. Alexis; Jerry Tan; Emmy Graber; Jonette Keri; Heather C. Woolery-Lloyd; Julie C. Harper; Fran E. Cook-Bolden; Adarsh Konda
    Poster Abstract

  • 12343 - Egeberg
    Baseline Characteristics and Interim Month 12 mNAPSI Results in Patients With Moderate-to-Severe Plaque Psoriasis and Concomitant Nail Psoriasis Treated With Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
    Alexander Egeberg, Andreas Pinter, Ronald Vender, Shirin Zaheri, Alan Brnabic, Christopher Schuster, Mohamed Elrayes, Catherine Reed, Elisabeth Riedl, Luis Puig
    Poster Abstract

  • 12348 - Eichenfield
    Management of Mild-to-Moderate Atopic Dermatitis With Topical Treatments in Real-World Practice
    Lawrence F. Eichenfield, Linda F. Stein Gold, Adelaide A. Hebert, Lyn Guenther, James Bergman, Yulia Valdman-Grinshpoun, Ben Amitai, Roni P. Dodiuk Gad, Michael J. Cork, Valeria Aoki, Chia-Yu Chu,Jianzhong Zhang, Lin Ma, Hidehisa Saeki,Paula C. Luna, Mark J. Koh, Ashraf Reda
    Poster Abstract

  • 12349 - Eichenfield
    Long-term safety and efficacy of clascoterone cream 1% in patients ≥12 years old with acne vulgaris
    Lawrence F. Eichenfield, Adelaide A. Hebert, Linda Stein Gold, Martina Cartwright, Luigi Moro, Jenny Han, Nicholas Squittieri, Alessandro Mazzetti
    Poster Abstract

  • 12347 - Eichenfield
    Maintenance of Investigator’s Static Global Assessment Response With Once-Daily Crisaborole in Participants With Mild-to-Moderate Atopic Dermatitis
    Lawrence F. Eichenfield, Linda F. Stein Gold, Charles Lynde, Lyn Guenther, Shoshana Greenberger, Chia-Yu Chu, Ashraf Reda, Chuanbo Zang, Bonnie Vlahos, Paul Sanders, Amy Cha, Juliana M. Canosa
    Poster Abstract

  • 12346 - Eichenfield
    Efficacy Outcomes by Age and Race: A Post Hoc Analysis of Patients With Mild-to-Moderate Atopic Dermatitis Treated With Twice-Daily Crisaborole During the 8 Week Open-Label Period of the CrisADe CONTROL Trial
    Lawrence F. Eichenfield, Linda F. Stein Gold, Charles W. Lynde, Daniela E. Myers, Paul Sanders, Chuanbo Zang, Amy Cha, Shoshana Greenberger, Lin Ma, Roni Adiri
    Poster Abstract

  • 12345 - Eichenfield
    First and Second Flare-Free Maintenance at 52 Weeks: A Post Hoc Analysis of Once-Daily Crisaborole as a Long-Term Maintenance Treatment in Patients With Mild-to-Moderate Atopic Dermatitis (CrisADe CONTROL)
    Lawrence F. Eichenfield, Linda Stein Gold, Charles Lynde, Paul Sanders, Chuanbo Zang, Amy Cha, Shoshana Greenberger, Lin Ma, Juliana M. Canosa, Roni Adiri
    Poster Abstract

  • 12344 - Eichenfield
    Flare-Free Maintenance and Safety Outcomes Through 52 Weeks by Age and Race: A Post Hoc Analysis of Once-Daily Crisaborole as a Long-Term Maintenance Treatment in Participants With Mild-to-Moderate Atopic Dermatitis (CrisADe CONTROL)
    Lawrence F. Eichenfield, Linda F. Stein Gold, Charles W. Lynde, Paul Sanders, Chuanbo Zang, Juliana M. Canosa, Amy Cha, Shoshana Greenberger, Lin Ma, Roni Adiri
    Poster Abstract

  • 12351 - Fiorillo
    Efficacy and Safety Results of Apremilast in Pediatric Patients With Moderate to Severe Plaque Psoriasis: 16-Week Results From SPROUT, a Phase 3, Randomized, Controlled Study
    Loretta Fiorillo, Emily Becker, Raul de Lucas, Anna Belloni-Fortina, Susana Armesto, Peter Maes, Rajneet K. Oberoi, Maria Paris, Wendy Zhang, Zuoshun Zhang, Lisa Arkin
    Poster Abstract

  • 12352 - Gardner
    Impact of the COVID-19 Pandemic Among Persons Living With Vitiligo: Findings From the Global VALIANT Survey
    Jackie Gardner, BA, Iltefat H. Hamzavi, MD, Mukta Tulpule, MBBS, John E. Harris, MD, PhD, Yan Valle, MSc, MBA, Gaone Tlhong Matewa, BBA, Kristen Bibeau, PhD, MSPH, Jessy Gao, MA, Haobo Ren, PhD, Khaled Ezzedine, MD, PhD
    Poster Abstract

  • 12353 - Gold
    Safety of Lebrikizumab in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: Data From 8 Trials
    Linda Stein Gold, Diamant Thaçi, Jacob Thyssen, Melinda Gooderham, Vivian Laquer, Chitra R. Natalie, Fangyi Zhao, Eric Meskimen, Hany Elmaraghy, Sonia Montmayeur, Gemma Jimenez, Marjolein de Bruin-Weller
    Poster Abstract

  • 12354 - Gooderham
    Deucravacitinib, an oral, selective, allosteric tyrosine kinase 2 inhibitor, in moderate to severe plaque psoriasis: efficacy by baseline demographic and disease characteristics in the phase 3 POETYK PSO-1 and PSO-2 trials
    Melinda Gooderham, Lynda Spelman, Shinichi Imafuku, Marco Romanelli, Joseph F. Merola, April W. Armstrong, Elizabeth Colston, Subhashis Banerjee, Thomas Scharnitz, Andrew Blauvelt
    Poster Abstract

  • 12355 - Gupta
    Treatment of Onychomycosis in an Era of Antifungal Resistance: Role for Antifungal Stewardship and Topical Antifungal Agents
    Aditya K Gupta; Boni Elewski; Warren S Joseph; Shari R Lipner; C Ralph Daniel; Antonella Tosti; Eric Guenin; Mahmoud Ghannoum
    Poster Abstract

  • 12356 - Guttman-Yassky
    Efficacy of Lebrikizumab in Patients Who Did Not Achieve Protocol-Defined Criteria for Response After Initial 16 Weeks of Therapy
    Emma Guttman-Yassky, David Rosmarin, Jacob P. Thyssen, Stephan Weidinger, Thomas Bieber, Hany Elmaraghy, Amber Reck Atwater, Evangeline Pierce, Chenjia Xu, Helena Agell, Eric Simpson
    Poster Abstract

  • 12357 - Harris
    Relapse and Maintenance of Clinical Response In the Randomized Withdrawal Arm of the TRuE-V Long-Term Extension Phase 3 Study of Ruxolitinib Cream in Vitiligo
    John E. Harris, MD, PhD, Kim Papp, MD, PhD, Seth B. Forman, MD, Jacek Zdybski, MD, PhD, Amit G. Pandya, MD, Julien Seneschal, MD, PhD, Deanna Kornacki, PhD, Kathleen Butler, MD, Shaoceng Wei, PhD, Thierry Passeron, MD, PhD
    Poster Abstract

  • 12358 - Hartman
    Melanoma Detection in the Medicare Population: Sub-analysis of DERM-ASSESS III, a Validation Study of a Handheld Elastic Scattering Spectroscopy Device on Lesions Suggestive of Melanoma
    Rebecca I Hartman, MD, MPH; Kelly Tepedino, MD; Maxwell A Fung, MD; Jennifer M McNiff, MD; Vivien L Nguyen, PharmD; Kiran Chatha, MD; Jane M Grant-Kels, MD
    Poster Abstract